Works by Neuen, Brendon L.

Results: 54

Diabetic kidney disease The four pillars of therapy.
Published in:
Medicine Today, 2024, v. 25, n. 12, p. 10
By:
- ZHENG, CATHERINE;
- MATHER, AMANDA;
- ROXBURGH, SARAH;
- NEUEN, BRENDON L.;
- HA, JEFFREY T.
Publication type:
Article
Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults.
Published in:
Nephrology, 2017, v. 22, n. 7, p. 520, doi. 10.1111/nep.12816
By:
- Greenwood, Alice M;
- Gunnarsson, Ronny;
- Neuen, Brendon L;
- Oliver, Kimberley;
- Green, Stella J;
- Baer, Richard A
Publication type:
Article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Published in:
Annals of Internal Medicine, 2019, v. 171, n. 3, p. 181, doi. 10.7326/M19-0087
By:
- Ha, Jeffrey T.;
- Neuen, Brendon L.;
- Cheng, Lap P.;
- Jun, Min;
- Toyama, Tadashi;
- Gallagher, Martin P.;
- Jardine, Meg J.;
- Sood, Manish M.;
- Garg, Amit X.;
- Palmer, Suetonia C.;
- Mark, Patrick B.;
- Wheeler, David C.;
- Jha, Vivekanand;
- Freedman, Ben;
- Johnson, David W.;
- Perkovic, Vlado;
- Badve, Sunil V.
Publication type:
Article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Published in:
2019
By:
- Ha, Jeffrey T;
- Neuen, Brendon L;
- Cheng, Lap P;
- Jun, Min;
- Toyama, Tadashi;
- Gallagher, Martin P;
- Jardine, Meg J;
- Sood, Manish M;
- Garg, Amit X;
- Palmer, Suetonia C;
- Mark, Patrick B;
- Wheeler, David C;
- Jha, Vivekanand;
- Freedman, Ben;
- Johnson, David W;
- Perkovic, Vlado;
- Badve, Sunil V
Publication type:
journal article
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.
Published in:
Diabetes Care, 2024, v. 47, n. 3, p. 501, doi. 10.2337/dc23-1450
By:
- Tobe, Sheldon W.;
- Mavrakanas, Thomas A.;
- Bajaj, Harpreet S.;
- Levin, Adeera;
- Tangri, Navdeep;
- Slee, April;
- Neuen, Brendon L.;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.;
- Rapattoni, Wally;
- Ang, Fernando G.
Publication type:
Article
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.
Published in:
2022
By:
- Koshino, Akihiko;
- Schechter, Meir;
- Sen, Taha;
- Vart, Priya;
- Neuen, Brendon L.;
- Neal, Bruce;
- Arnott, Clare;
- Perkovic, Vlado;
- Ridker, Paul M.;
- Tuttle, Katherine R.;
- Hansen, Michael K.;
- Heerspink, Hiddo J.L.
Publication type:
journal article
Reducing cardiovascular risk in people with diabetes and kidney disease.
Published in:
2018
By:
- Neuen, Brendon L.;
- Perkovic, Vlado
Publication type:
journal article
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
Published in:
Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 997, doi. 10.1111/dom.16061
By:
- Milder, Tamara Y.;
- Lin, Jialing;
- Pearson, Sallie‐Anne;
- de Oliveira Costa, Juliana;
- Neuen, Brendon L.;
- Pollock, Carol;
- Jun, Min;
- Greenfield, Jerry R.;
- Day, Richard O.;
- Stocker, Sophie L.;
- Brieger, David;
- Falster, Michael O.
Publication type:
Article
An overview of the CANVAS Program and CREDENCE trial: The primary outcomes and key clinical implications for those managing patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, p. 5, doi. 10.1111/dom.15751
By:
- Chen, Angela X.;
- Fletcher, Robert;
- Neuen, Brendon L.;
- Neal, Bruce;
- Arnott, Clare
Publication type:
Article
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678
By:
- Tangri, Navdeep;
- Ferguson, Thomas W.;
- Bamforth, Ryan J.;
- Leon, Silvia J.;
- Arnott, Clare;
- Mahaffey, Kenneth W.;
- Kotwal, Sradha;
- Heerspink, Hiddo J. L.;
- Perkovic, Vlado;
- Fletcher, Robert A.;
- Neuen, Brendon L.
Publication type:
Article
Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2787, doi. 10.1111/dom.15597
By:
- de Oliveira Costa, Juliana;
- Lin, Jialing;
- Milder, Tamara Y.;
- Greenfield, Jerry R.;
- Day, Richard O.;
- Stocker, Sophie L.;
- Neuen, Brendon L.;
- Havard, Alys;
- Pearson, Sallie‐Anne;
- Falster, Michael O.
Publication type:
Article
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340
By:
- Sharma, Abhinav;
- Marques, Pedro;
- Neuen, Brendon L.;
- Fletcher, Robert A.;
- Slee, April;
- Rapattoni, Wally;
- Ang, Fernando G.;
- Arnott, Clare;
- Levin, Adeera;
- Verma, Subodh;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.
Publication type:
Article
The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3724, doi. 10.1111/dom.15267
By:
- Yu, Jie;
- Sweeting, Arianne N.;
- Gianacas, Chris;
- Houston, Lauren;
- Lee, Vivian;
- Fletcher, Robert A.;
- Perkovic, Vlado;
- Li, Qiang;
- Neuen, Brendon L.;
- Berwanger, Otavio;
- Heerspink, Hiddo J. L.;
- de Zeeuw, Dick;
- Arnott, Clare
Publication type:
Article
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
By:
- Heerspink, Hiddo J. L.;
- Vart, Priya;
- Jongs, Niels;
- Neuen, Brendon L.;
- Bakris, George;
- Claggett, Brian;
- Vaduganathan, Muthiah;
- McCausland, Finnian;
- Docherty, Kieran F.;
- Jhund, Pardeep S.;
- Solomon, Scott D.;
- Perkovic, Vlado;
- McMurray, John J. V.
Publication type:
Article
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2331, doi. 10.1111/dom.15112
By:
- Sridhar, Vikas S.;
- Neuen, Brendon L.;
- Fletcher, Robert A.;
- Slee, April;
- Ang, Fernando G.;
- Rapattoni, Wally;
- Arnott, Clare;
- Cherney, David Z.;
- Perkovic, Vlado;
- Wheeler, David C.;
- Levin, Adeera
Publication type:
Article
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
By:
- Kang, Amy;
- Smyth, Brendan;
- Neuen, Brendon L.;
- Heerspink, Hiddo J. L.;
- Di Tanna, Gian Luca;
- Zhang, Hong;
- Arnott, Clare;
- Hockham, Carinna;
- Agarwal, Rajiv;
- Bakris, George;
- Charytan, David M.;
- de Zeeuw, Dick;
- Greene, Tom;
- Levin, Adeera;
- Pollock, Carol;
- Wheeler, David C.;
- Mahaffey, Kenneth W.;
- Perkovic, Vlado;
- Jardine, Meg J.
Publication type:
Article
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065
By:
- Yi, Tae Won;
- Wong, Michelle M.Y.;
- Neuen, Brendon L.;
- Arnott, Clare;
- Poirier, Paul;
- Seufert, Jochen;
- Slee, April;
- Rapattoni, Wally;
- Ang, Fernando G.;
- Wheeler, David C.;
- Mahaffey, Kenneth W.;
- Perkovic, Vlado;
- Levin, Adeera
Publication type:
Article
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2038, doi. 10.1111/dom.15057
By:
- Tsoukas, Michael A.;
- Woo, Vincent;
- Tobe, Sheldon W.;
- Slee, April;
- Rapattoni, Wally;
- Ang, Fernando G.;
- Seufert, Jochen;
- Neuen, Brendon L.;
- Arnott, Clare;
- Mahaffey, Kenneth W.;
- Wheeler, David C.
Publication type:
Article
The importance of targeting multiple risk markers in patients with type 2 diabetes: A post‐hoc study from the CANVAS programme.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1638, doi. 10.1111/dom.15018
By:
- Tye, SokCin;
- Oshima, Megumi;
- Arnott, Clare;
- Neuen, Brendon L.;
- Fletcher, Robert A.;
- Neal, Bruce;
- Heerspink, Hiddo J. L.
Publication type:
Article
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978
By:
- Koshino, Akihiko;
- Oshima, Megumi;
- Arnott, Clare;
- Fletcher, Robert A.;
- Bakris, George L.;
- Jardine, Meg;
- Mahaffey, Kenneth W.;
- Perkovic, Vlado;
- Pollock, Carol;
- Heerspink, Hiddo J. L.;
- Neuen, Brendon L.
Publication type:
Article
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
By:
- Li, Chao;
- Yu, Jie;
- Hockham, Carinna;
- Perkovic, Vlado;
- Neuen, Brendon L.;
- Badve, Sunil V.;
- Houston, Lauren;
- Lee, Vivian Y. J.;
- Barraclough, Jennifer Y.;
- Fletcher, Robert A.;
- Mahaffey, Kenneth W.;
- Heerspink, Hiddo J. L.;
- Cannon, Christopher P.;
- Neal, Bruce;
- Arnott, Clare
Publication type:
Article
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671
By:
- Barraclough, Jennifer Y.;
- Yu, Jie;
- Figtree, Gemma A.;
- Perkovic, Vlado;
- Heerspink, Hiddo J. L.;
- Neuen, Brendon L.;
- Cannon, Christopher P.;
- Mahaffey, Kenneth W.;
- Schutte, Aletta E.;
- Neal, Bruce;
- Arnott, Clare
Publication type:
Article
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
By:
- Arnott, Clare;
- Li, Jing‐Wei;
- Cannon, Christopher P.;
- Zeeuw, Dick;
- Neuen, Brendon L.;
- Heerspink, Hiddo J. L.;
- Charytan, David M.;
- Agarwal, Anubha;
- Huffman, Mark D.;
- Figtree, Gemma A.;
- Bakris, George;
- Chang, Tara I‐Hsin;
- Feng, Kent;
- Rosenthal, Norman;
- Zinman, Bernard;
- Jardine, Meg J.;
- Perkovic, Vlado;
- Neal, Bruce;
- Mahaffey, Kenneth W.
Publication type:
Article
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226
By:
- Neuen, Brendon L.;
- Arnott, Clare;
- Perkovic, Vlado;
- Figtree, Gemma;
- Zeeuw, Dick;
- Fulcher, Greg;
- Jun, Min;
- Jardine, Meg J.;
- Zoungas, Sophia;
- Pollock, Carol;
- Mahaffey, Kenneth W.;
- Neal, Bruce;
- Heerspink, Hiddo J. L.
Publication type:
Article
Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197
By:
- Li, Chao;
- Zhou, Zien;
- Neuen, Brendon L.;
- Yu, Jie;
- Huang, Yuli;
- Young, Tamara;
- Li, Jingwei;
- Li, Lin;
- Perkovic, Vlado;
- Jardine, Meg J.;
- Keay, Lisa;
- Markoulli, Maria;
- Rosenthal, Norm;
- Capuano, George;
- Yavin, Yshai;
- Neal, Bruce;
- Arnott, Clare
Publication type:
Article
The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.
Published in:
Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1753, doi. 10.1111/dom.14091
By:
- Arnott, Clare;
- Huang, Yuli;
- Neuen, Brendon L;
- Di Tanna, Gian Luca;
- Cannon, Christopher P.;
- Oh, Richard;
- Edwards, Robert;
- Kavalam, Mary;
- Rosenthal, Norman;
- Perkovic, Vlado;
- Jardine, Meg J;
- Mahaffey, Kenneth;
- Neal, Bruce
Publication type:
Article
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis.
Published in:
Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1237, doi. 10.1111/dom.13648
By:
- Toyama, Tadashi;
- Neuen, Brendon L.;
- Jun, Min;
- Ohkuma, Toshiaki;
- Neal, Bruce;
- Jardine, Meg J.;
- Heerspink, Hiddo L.;
- Wong, Muh Geot;
- Ninomiya, Toshiharu;
- Wada, Takashi;
- Perkovic, Vlado
Publication type:
Article
Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities.
Published in:
CardioRenal Medicine, 2022, v. 12, n. 1, p. 1, doi. 10.1159/000520909
By:
- Vijay, Kris;
- Neuen, Brendon L.;
- Lerma, Edgar V.
Publication type:
Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
Published in:
European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
By:
- Neuen, Brendon L;
- Oshima, Megumi;
- Perkovic, Vlado;
- Agarwal, Rajiv;
- Arnott, Clare;
- Bakris, George;
- Cannon, Christopher P;
- Charytan, David M;
- Edwards, Robert;
- Górriz, Jose L;
- Jardine, Meg J;
- Levin, Adeera;
- Neal, Bruce;
- Nicola, Luca De;
- Pollock, Carol;
- Rosenthal, Norman;
- Wheeler, David C;
- Mahaffey, Kenneth W;
- Heerspink, Hiddo J L
Publication type:
Article
Blood Pressure Effects of SGLT2 Inhibitors: Mechanisms and Clinical Evidence in Different Populations.
Published in:
Current Hypertension Reports, 2023, v. 25, n. 12, p. 429, doi. 10.1007/s11906-023-01281-1
By:
- Beal, Bryony;
- Schutte, Aletta E.;
- Neuen, Brendon L.
Publication type:
Article
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program.
Published in:
ESC Heart Failure, 2021, v. 8, n. 2, p. 1482, doi. 10.1002/ehf2.13236
By:
- Yu, Jie;
- Arnott, Clare;
- Neuen, Brendon L.;
- Heersprink, Hiddo L.;
- Mahaffey, Kenneth W.;
- Cannon, Christopher P.;
- Khan, Sadiya S.;
- Baldridge, Abigail S.;
- Shah, Sanjiv J.;
- Huang, Yuli;
- Li, Chao;
- Figtree, Gemma A.;
- Perkovic, Vlado;
- Jardine, Meg J.;
- Neal, Bruce;
- Huffman, Mark D.
Publication type:
Article
Neutrophil–lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients.
Published in:
Renal Failure, 2016, v. 38, n. 1, p. 70, doi. 10.3109/0886022X.2015.1104990
By:
- Neuen, Brendon L.;
- Leather, Nicole;
- Greenwood, Alice M.;
- Gunnarsson, Ronny;
- Cho, Yeoungjee;
- Mantha, Murty L.
Publication type:
Article
Risk factors for incident kidney disease in older adults: an Australian prospective population‐based study.
Published in:
Internal Medicine Journal, 2022, v. 52, n. 5, p. 808, doi. 10.1111/imj.15074
By:
- Kang, Amy;
- Sukkar, Louisa;
- Hockham, Carinna;
- Jun, Min;
- Young, Tamara;
- Scaria, Anish;
- Foote, Celine;
- Neuen, Brendon L.;
- Cass, Alan;
- Pollock, Carol;
- Comino, Elizabeth;
- Lung, Thomas;
- Pecoits‐Filho, Roberto;
- Rogers, Kris;
- Jardine, Meg J.
Publication type:
Article
Lupus nephritis in Indigenous Australians: a single‐centre study.
Published in:
Internal Medicine Journal, 2020, v. 50, n. 7, p. 830, doi. 10.1111/imj.14710
By:
- Nigam, Amit;
- Baer, Richard;
- Green, Stella;
- Neuen, Brendon L.;
- Vile, Alexander;
- Mantha, Murty
Publication type:
Article
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation.
Published in:
Clinical Kidney Journal, 2024, v. 17, n. 10, p. 1, doi. 10.1093/ckj/sfae270
By:
- Heine, Gunnar H;
- Schneppe, Carolin;
- Bauersachs, Rupert;
- Eitel, Ingo;
- Neuen, Brendon L;
- Ruff, Christian T;
- Schirmer, Stephan H;
- Vriese, An De
Publication type:
Article
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Published in:
Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132
By:
- Heerspink, Hiddo J L;
- Agarwal, Rajiv;
- Bakris, George L;
- Cherney, David Z I;
- Lam, Carolyn S P;
- Neuen, Brendon L;
- Sarafidis, Pantelis A;
- Tuttle, Katherine R;
- Wanner, Christoph;
- Brinker, Meike D;
- Dizayee, Sara;
- Kolkhof, Peter;
- Schloemer, Patrick;
- Vesterinen, Paula;
- Perkovic, Vlado;
- investigators, for the FIND-CKD
Publication type:
Article
Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
Published in:
Nephrology Dialysis Transplantation, 2025, v. 40, p. i59, doi. 10.1093/ndt/gfae258
By:
- Neuen, Brendon L;
- Yeung, Emily K;
- Rangaswami, Janani;
- Vaduganathan, Muthiah
Publication type:
Article
SGLT2 inhibitors and finerenone: one or the other or both?
Published in:
Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1209, doi. 10.1093/ndt/gfac046
By:
- Neuen, Brendon L;
- Jardine, Meg J
Publication type:
Article
Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
Published in:
Nephrology Dialysis Transplantation, 2020, v. 35, p. i48, doi. 10.1093/ndt/gfz252
By:
- Neuen, Brendon L;
- Jardine, Meg J;
- Perkovic, Vlado
Publication type:
Article
The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study.
Published in:
European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-02214-7
By:
- Yang, Hao;
- Yang, Lili;
- Jardine, Meg J.;
- Arnott, Clare;
- Neuen, Brendon L.;
- Xu, Kexi;
- Zhao, Xiaohui;
- Qian, Dehui;
- Cui, Bin;
- Qiu, Youzhu;
- Huang, Yuli;
- Yu, Jie;
- Wang, Jiang;
- Yu, Shiyong;
- Tan, Hu;
- Huang, Lan;
- Li, Jing-Wei;
- Jin, Jun
Publication type:
Article
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Published in:
2020
By:
- Arnott, Clare;
- Qiang Li;
- Kang, Amy;
- Neuen, Brendon L.;
- Bompoint, Severine;
- Lam, Carolyn S. P.;
- Rodgers, Anthony;
- Mahaffey, Kenneth W.;
- Cannon, Christopher P.;
- Perkovic, Vlado;
- Jardine, Meg J.;
- Neal, Bruce;
- Li, Qiang
Publication type:
journal article
Use of, time to, and type of first add‐on anti‐hyperglycaemic therapy to metformin in Australia, 2018–2022.
Published in:
British Journal of Clinical Pharmacology, 2025, v. 91, n. 1, p. 117, doi. 10.1111/bcp.16231
By:
- Milder, Tamara Y.;
- Lin, Jialing;
- Pearson, Sallie‐Anne;
- Greenfield, Jerry R.;
- Day, Richard O.;
- Stocker, Sophie L.;
- Neuen, Brendon L.;
- Falster, Michael O.;
- de Oliveira Costa, Juliana
Publication type:
Article
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant‐level pooled analysis from the CANVAS Program and CREDENCE trial.
Published in:
European Journal of Heart Failure, 2024, v. 26, n. 9, p. 1967, doi. 10.1002/ejhf.3292
By:
- Vaduganathan, Muthiah;
- Cannon, Christopher P.;
- Jardine, Meg J.;
- Heerspink, Hiddo J.L.;
- Arnott, Clare;
- Neuen, Brendon L.;
- Sarraju, Ashish;
- Gogate, Jagadish;
- Seufert, Jochen;
- Neal, Bruce;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.;
- Kosiborod, Mikhail N.
Publication type:
Article
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial.
Published in:
Journal of the American Heart Association, 2024, v. 13, n. 3, p. 1, doi. 10.1161/JAHA.123.031586
By:
- Sharma, Abhinav;
- Razaghizad, Amir;
- Joury, Abdulaziz;
- Levin, Adeera;
- Bajaj, Harpreet S.;
- Mancini, G. B. John;
- Wong, Norman C.;
- Slee, April;
- Ang, Fernando G.;
- Rapattoni, Wally;
- Neuen, Brendon L.;
- Arnott, Clare;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.
Publication type:
Article
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.
Published in:
Journal of the American Heart Association, 2023, v. 12, n. 13, p. 1, doi. 10.1161/JAHA.122.028516
By:
- Fletcher, Robert A.;
- Arnott, Clare;
- Rockenschaub, Patrick;
- Schutte, Aletta E.;
- Carpenter, Lewis;
- Vaduganathan, Muthiah;
- Agarwal, Rajiv;
- Bakris, George;
- Chang, Tara I.;
- Heerspink, Hiddo J. L.;
- Jardine, Meg J.;
- Mahaffey, Kenneth W.;
- Neal, Bruce;
- Pollock, Carol;
- Jun, Min;
- Rodgers, Anthony;
- Perkovic, Vlado;
- Neuen, Brendon L.
Publication type:
Article
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
Published in:
2021
By:
- Taha Sen;
- Jingwei Li;
- Neuen, Brendon L.;
- Arnott, Clare;
- Neal, Bruce;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.;
- Shaw, Wayne;
- Canovatchel, William;
- Hansen, Michael K.;
- Heerspink, Hiddo J. L.;
- Sen, Taha;
- Li, Jingwei
Publication type:
journal article
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure.
Published in:
2022
By:
- Vaduganathan, Muthiah;
- Ferreira, João Pedro;
- Rossignol, Patrick;
- Neuen, Brendon L.;
- Claggett, Brian L.;
- Pfeffer, Marc A.;
- McMurray, John J.V.;
- Pitt, Bertram;
- Zannad, Faiez;
- Solomon, Scott D.
Publication type:
journal article
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program.
Published in:
Diabetologia, 2021, v. 64, n. 11, p. 2402, doi. 10.1007/s00125-021-05524-1
By:
- Young, Tamara K.;
- Li, Jing-Wei;
- Kang, Amy;
- Heerspink, Hiddo J. L.;
- Hockham, Carinna;
- Arnott, Clare;
- Neuen, Brendon L.;
- Zoungas, Sophia;
- Mahaffey, Kenneth W.;
- Perkovic, Vlado;
- de Zeeuw, Dick;
- Fulcher, Greg;
- Neal, Bruce;
- Jardine, Meg
Publication type:
Article
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
Published in:
Diabetologia, 2021, v. 64, n. 10, p. 2147, doi. 10.1007/s00125-021-05512-5
By:
- Sen, Taha;
- Li, Jingwei;
- Neuen, Brendon L.;
- Neal, Bruce;
- Arnott, Clare;
- Parikh, Chirag R.;
- Coca, Steven G.;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.;
- Yavin, Yshai;
- Rosenthal, Norman;
- Hansen, Michael K.;
- Heerspink, Hiddo J. L.
Publication type:
Article
Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis.
Published in:
International Journal of Vascular Medicine, 2015, p. 1, doi. 10.1155/2015/971202
By:
- Neuen, Brendon L.;
- Baer, Richard A.;
- Grainer, Frank;
- Mantha, Murty L.
Publication type:
Article